Latest Asx News

Austin Metals has raised $3 million through a well-supported share placement to accelerate drilling at its Austin Gold Project in Western Australia’s Murchison region.

Dome Gold Mines Ltd is launching a $7 million convertible note offering aimed at funding key developments in its Fiji mining projects, including the Sigatoka feasibility study and exploration programs.

Star Minerals has received mining approval for its Tumblegum South Gold Project, setting the stage for mining to commence in early 2026. With robust production targets and a key partnership in place, the project is poised to advance swiftly.

Venari Minerals has taken a strategic step to de-risk its Red Mountain Lithium Project by securing private water rights and land in Nevada, a critical resource in the arid region. This move, alongside ongoing metallurgical testwork and an upcoming resource estimate, positions the project for advancement.

Medallion Metals and IGO Limited have agreed to extend the deadline for completing the Forrestania Nickel Operation acquisition, allowing more time to meet key conditions and secure environmental approvals.

Mayne Pharma has rejected Cosette Pharmaceuticals’ notice to terminate their merger agreement, citing Cosette’s failure to meet obligations that led to regulatory approval issues. The dispute raises fresh uncertainty over the proposed acquisition’s future.

Orion Minerals has responded to an ASX price query following a recent uptick in its share price, confirming no undisclosed material information exists while highlighting ongoing financing talks with Glencore.

Torque Metals has raised $15 million in a placement led by top-tier global investors, setting the stage for an aggressive drilling campaign at its Paris Gold Project in Western Australia.

High-Tech Metals Limited is advancing near-term gold production at its Mt Fisher and Mt Eureka projects, leveraging historical stockpiles and high-grade resources while pursuing aggressive exploration to expand its resource base.

Memphasys Limited has restructured its leadership by eliminating the CEO role to back a direct-selling global commercialisation strategy for its Felix™ System, anticipating imminent CE Mark approval to enter the European IVF market.

LTR Pharma has received regulatory clearance from the Therapeutic Goods Administration to commence its Phase II clinical trial of SPONTAN, focusing on men aged 65 and over. Patient recruitment is set to begin early next year, aiming to address a key gap in erectile dysfunction treatment.

Astral Resources has successfully raised A$65 million through a strongly supported placement to advance its Mandilla Gold Project and accelerate exploration across its Western Australian gold assets.